pyrazolanthrone has been researched along with Brain Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, YI; Jung, S; Li, CH; Lim, SH; Ryu, HH | 1 |
| Choi, JM; Jang, WY; Jeong, YI; Jung, S; Li, CH; Lim, SH | 1 |
| Auf, G; Bikfalvi, A; Delugin, M; Favereaux, A; Guérit, S; Jabouille, A; Maitre, M; Minchenko, D; Minchenko, O; Moenner, M; North, S; Pineau, R; Platonova, N; Seno, M; Vajkoczy, P | 1 |
| Hirose, Y; Kawase, T; Ohba, S; Sano, H | 1 |
| Chen, GJ; Li, XS; Ran, JH; Tan, Y; Tang, WY; Yan, Y; Zhang, XD; Zhong, D | 1 |
| Chen, G; Gu, B; Gu, PY; Hu, WX; Huang, JY; Li, JY; Li, M; Ren, KW; Wei, D; Xing, B; Zhang, GF | 1 |
6 other study(ies) available for pyrazolanthrone and Brain Neoplasms
| Article | Year |
|---|---|
Synergistic Effects of Radiotherapy With JNK Inhibitor-Incorporated Nanoparticle in an Intracranial Lewis Lung Carcinoma Mouse Models.
Topics: Animals; Apoptosis; Brain Neoplasms; Carcinoma, Lewis Lung; Caspase 3; Mice; Nanoparticles | 2023 |
Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models.
Topics: Animals; Anthracenes; Apoptosis; Biological Availability; Brain Neoplasms; Carcinoma, Lewis Lung; DNA Damage; Drug Delivery Systems; Female; Gamma Rays; Humans; Hydrogen-Ion Concentration; JNK Mitogen-Activated Protein Kinases; Methyltransferases; Mice, Inbred C57BL; Nanoparticles; Neoplasms, Experimental; Polyethylene Glycols; Radiation-Sensitizing Agents; Tumor Microenvironment | 2019 |
High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.
Topics: Animals; Anthracenes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Autocrine Communication; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cetuximab; Endoribonucleases; Epidermal Growth Factor; Epiregulin; ErbB Receptors; Gene Expression; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Protein Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2013 |
Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells.
Topics: Activating Transcription Factor 2; Anthracenes; Antineoplastic Agents, Alkylating; beta-Galactosidase; Brain Neoplasms; Cell Death; Cell Division; Cell Line, Tumor; Cell Survival; Cellular Senescence; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; G2 Phase; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Temozolomide; Tumor Suppressor Protein p53 | 2009 |
Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling.
Topics: Anthracenes; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Chromones; Focal Adhesion Protein-Tyrosine Kinases; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Morpholines; Neoplasm Invasiveness; Phosphorylation; Proto-Oncogene Proteins c-akt; Syntenins | 2012 |
SP600125, a JNK inhibitor, suppresses growth of JNK-inactive glioblastoma cells through cell-cycle G2/M phase arrest.
Topics: Anthracenes; Benzimidazoles; Blotting, Western; Brain Neoplasms; CDC2 Protein Kinase; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Flow Cytometry; Fluorescent Dyes; G2 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; M Phase Cell Cycle Checkpoints; MAP Kinase Kinase 4; Vacuoles | 2012 |